The Utility of Pericapsular Nerve Group (PENG) Block versus Intrathecal Morphine for Postoperative Analgesia in Anterior Approach Total Hip Arthroplasty: A Multicentre Triple Blinded Randomised Controlled Trial

Phase 4

• Conditions: Hip Arthroplasty; Pain Management; Anaesthesiology - Pain management; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12623001309673
• Lead Sponsor: Tim Cheok

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-12-15
• Last Update Posted: 8 January 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

All adult patients above the age of 18 years old presenting for primary elective anterior approach Total Hip Arthroplasty (THA) under spinal anaesthesia will be invited to participate in our study. Included participants must be able to provide informed consent and reliably report symptoms to the research team.

Exclusion Criteria

We will exclude patients who are (1) unable to provide first party consent (e.g., due to cognitive impairment or language barrier), (2) procedure not performed via an anterior approach, (3) contraindications for any of the following: spinal, intrathecal morphine or PENG block (e.g. therapeutic anticoagulation, anaphylaxis to local anaesthetics or morphine), (4) patient refusal of spinal anaesthesia and/or regional analgesia, and (5) clinical indications for general anaesthesia rather than spinal anaesthesia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dynamic pain score [Numerical pain scale from zero to ten 3 and 24 hours postoperatively]